title: Oral heart failure medications: an update for home health clinicians.
abstract: Heart failure in the United States is a growing epidemic, with approximately 550,000 new cases per year. An increasing number of patients are treated at home with drugs that require a working knowledge of both the syndrome and the various therapeutic agents in use. New understanding of the syndrome has led to a paradigm shift from treating signs and symptoms to increasing long-term survival. This article focuses on the syndrome as it relates to common agents prescribed for the patient in the home setting.
authors.affiliation: Texas Christian University, Harris College of Nursing and Health Sciences & School of Nurse Anesthesia, TCU Box 298620, Fort Worth, Texas 76129, USA. d.cheek@tcu.edu
authors.forename: Dennis J
authors.initials: DJ
authors.lastname: Cheek
authors.forename: Melissa M
authors.initials: MM
authors.lastname: Sherrod
authors.forename: Roger
authors.initials: R
authors.lastname: Graulty
authors.forename: Johnathon
authors.initials: J
authors.lastname: Hawkins
mesh_terms: D000284:Administration, Oral; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D006699:Home Care Services / Q000706:statistics & numerical data*; D006801:Humans; D017211:Treatment Failure
chemical_list: D002316:Cardiotonic Agents